AstraZeneca (AZN) Commits $50 Billion to U.S. Manufacturing Growth
AstraZeneca has just made a massive move that could change the face of American pharmaceutical manufacturing. The British drugmaker, known for its innovations in cancer and respiratory treatments, has committed a whopping $50 billion to expand its manufacturing and research operations in the United States by 2030.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
